Advertisement

Role of MRI, Ultrasound, and Computed Tomography in the Management of Prostate Cancer

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to PET Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Barsouk A.
        • Padala S.A.
        • Vakiti A.
        • et al.
        Epidemiology, staging and management of prostate cancer.
        Med Sci. 2020; 8: 28
        • de Rooj M.
        Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis.
        Eur Urol. 2016; 70: 233-245
        • Hoeks C.M.
        • Barentsz J.O.
        • Hambrock T.
        • et al.
        Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
        Radiology. 2011; 261: 46-66
      1. Multiparametric MR imaging of the prostate after treatment of prostate cancer.
        RadioGraphics. 2019; https://doi.org/10.1148/rg.2018170147.podcast
        • Perez-Lopez R.
        • Tunariu N.
        • Padhani A.R.
        • et al.
        Imaging diagnosis and follow-up of advanced prostate cancer: clinical perspectives and state of the art.
        Radiology. 2019; 292: 273-286
        • Risko R.
        • Merdan S.
        • Womble P.R.
        • et al.
        Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer.
        Urology. 2014; 84: 1329-1334
        • Stavrinides V.
        • Giganti F.
        • Emberton M.
        • et al.
        MRI in active surveillance: a critical review.
        Prostate Cancer Prostatic Dis. 2018; 22: 5-15
        • Turpin A.
        • Girard E.
        • Baillet C.
        • et al.
        Imaging for metastasis in prostate cancer: a review of the literature.
        Front Oncol. 2020; 10
        • Yablon C.M.
        • Banner M.P.
        • Ramchandani P.
        • et al.
        Complications of prostate cancer treatment: spectrum of imaging findings.
        RadioGraphics. 2004; 24https://doi.org/10.1148/rg.24si045502
        • Tharmalingam H.
        • Alonzi R.
        • Hoskin P.J.
        The role of magnetic resonance imaging in brachytherapy.
        Clin Oncol. 2018; 30: 728-736
        • Sankineni S.
        • Brown A.M.
        • Fascelli M.
        • et al.
        Lymph node staging in prostate cancer.
        Curr Urol Rep. 2015; 16https://doi.org/10.1007/s11934-015-0505-y
        • Ma B.
        • Wells A.
        • Wei L.
        • et al.
        Prostate cancer liver metastasis: dormancy and resistance to therapy.
        Semin Cancer Biol. 2021; 71: 2-9
        • You C.
        • Li X.
        • Du Y.
        • et al.
        The micro-ultrasound guided prostate biopsy in detection of prostate cancer: a systematic review and meta-analysis.
        J Endourology. 2021; https://doi.org/10.1089/end.2021.0361
        • Xu K.M.
        • Chen R.C.
        • Schuster D.M.
        • et al.
        Role of novel imaging in the management of prostate cancer.
        Urol Oncol Semin Original Invest. 2019; 37: 611-618
        • Leslie S.W.
        Prostate cancer. StatPearls [Internet].
        (Available at:) (Accessed February 1, 2022)
        • Sanda M.G.
        • Cadeddu J.A.
        • Kirkby E.
        • et al.
        Clinically localized prostate cancer: AUA/Astro/SUO guideline. part I: risk stratification, shared decision making, and Care Options.
        J Urol. 2018; 199: 683-690
        • Sanda M.G.
        • Cadeddu J.A.
        • Kirkby E.
        • et al.
        Clinically localized prostate cancer: AUA/Astro/SUO guideline. part II: recommended approaches and details of specific care options.
        J Urol. 2018; 199: 990-997
      2. Using the Cambridge prognostic groups for risk.
        (Available at:) (Accessed February 1, 2022)
        • Pierorazio P.M.
        • Walsh P.C.
        • Partin A.W.
        • et al.
        Prognostic gleason grade grouping: data based on the modified Gleason Scoring System.
        BJU Int. 2013; 111: 753-760
        • D'Amico A.V.
        Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
        JAMA. 1998; 280: 969
        • Cvon S.
        • Dickinson L.
        • Pendsé D.
        MRI in the management of prostate cancer.
        Semin Ultrasound CT MRI. 2020; 41: 366-372
        • Itatani R.
        • Namimoto T.
        • Atsuji S.
        • et al.
        Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies.
        Eur J Radiol. 2014; 83: 1740-1745
        • Ahmed H.U.
        • El-Shater Bosaily A.
        • Brown L.C.
        • et al.
        Diagnostic accuracy of multi-parametric MRI and trus biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
        Lancet. 2017; 389: 815-822
        • Brown L.C.
        • Ahmed H.U.
        • Faria R.
        • et al.
        Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
        Health Technol Assess. 2018; 22: 1-176
        • Rosenkrantz A.B.
        • Shanbhogue A.K.
        • Wang A.
        • et al.
        Length of capsular contact for diagnosing extraprostatic extension on Prostate MRI: assessment at an optimal threshold.
        J Magn Reson Imaging. 2015; 43: 990-997
        • Mehralivand S.
        • Shih J.H.
        • Harmon S.
        • et al.
        A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI.
        Radiology. 2019; 290: 709-719
        • Venkatesan A.M.
        • Mudairu-Dawodu E.
        • Duran C.
        • et al.
        Detecting recurrent prostate cancer using multiparametric MRI, influence of PSA and Gleason Grade.
        Cancer Imaging. 2021; 21https://doi.org/10.1186/s40644-020-00373-4
        • Bedir F.
        • Keske M.
        • Demirdogen S.O.
        • et al.
        Diagnosis and conservative management of ureteral orifice injury during robotic prostatectomy for a large prostate with a prominent median lobe.
        J Endourology Case Rep. 2019; 5: 39-41
        • vanSonnenberg E.
        • Wittich G.R.
        • Casola G.
        • et al.
        Lymphoceles: imaging characteristics and percutaneous management.
        Radiology. 1986; 161: 593-596
        • McLaughlin M.F.
        • Folkert M.R.
        • Timmerman R.D.
        • et al.
        Hydrogel spacer rectal wall infiltration associated with severe rectal injury and related complications after dose intensified prostate cancer stereotactic ablative radiation therapy.
        Adv Radiat Oncol. 2021; 6: 100713
        • Fischer-Valuck B.W.
        • Chundury A.
        • Gay H.
        • et al.
        Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.
        Pract Radiat Oncol. 2017; 7: 195-202
        • Sachdeva S.
        • Udechukwu N.S.
        • Elbelasi H.
        • et al.
        Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiography.
        Radiol Case Rep. 2017; 12: 31-33
        • Nag S.
        • Scaperoth D.D.
        • Badalament R.
        • et al.
        Transperineal Palladium 103 prostate brachytherapy: analysis of morbidity and seed migration.
        Urology. 1995; 45: 87-92
        • Merrick G.
        • Benson M.L.
        • Lief J.H.
        • et al.
        Seed fixity in the prostate/periprostatic region following brachytherapy. International journal of radiation oncology, biology, physics.
        (Available at:) (Accessed February 1, 2022)
        • Laurence Klotz C.M.
        Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer?.
        Eur Urol Focus. 2020; 6: 419-423